EyePoint, Inc. (EYPT) stock

EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30

$0.31−0.01 (-4.23%)

Close on Nov 13, 2026Market cap $26.38MP/E –Yield –

EyePoint EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

EyePoint's EV/EBITDA was 13.1× on Oct 30, 2015, against 8.1× a year earlier.

Period	Period end	Value	Change (pts)
2015	Oct 30, 2015	13.1×	+3.5
2014	Dec 31, 2014	9.6×	+1.6
2011	Jul 29, 2011	8.1×	−0.9
2010	Dec 31, 2010	8.9×	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is EYPT.

Revenue growth-93.9% · median -21.6%

Operating margin-13642.0% · median -651.0%

Net margin-13281.2% · median -649.0%

Advertisement
300 × 250

See a number that looks wrong?